TCL Archive NCI Nears Confrontation Over Construction As OMB Continues Obstructionist Policies July 11, 1975
TCL Archive Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products June 3, 2011
TCL Archive The Impact of Triple Calamities: Flat Funding, the End of ARRA, and a Dramatic Loss of Purchasing Power October 31, 2014